Corriente Advisors’s Eiger BioPharmaceuticals EIGR Stock Holding History
Bought
Maintained
Sold
Other funds holding EIGR
6CM
KCM
Corriente Advisors's EIGR Position: Q1 2020 in Review
Corriente Advisors sold out of Eiger BioPharmaceuticals (EIGR) in Q1 2020, closing a stake of 6,797 shares — an estimated $3.04M sold.
Corriente Advisors first reported a position in EIGR in Q4 2019 and held it in 1 quarter. The position peaked at $3.04M in Q4 2019. 93 funds tracked by Wall St. Rank hold EIGR as of Q1 2020.
- Corriente Advisors reported no remaining Eiger BioPharmaceuticals position as of Q1 2020 after selling out during the quarter.
- Corriente Advisors sold 6,797 Eiger BioPharmaceuticals shares in Q1 2020, an estimated $3.04M.
- Corriente Advisors first reported a position in Eiger BioPharmaceuticals in Q4 2019 and held it in 1 quarter.
- Corriente Advisors's Eiger BioPharmaceuticals position peaked at $3.04M in Q4 2019.
- 93 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals as of Q1 2020.
Based on Corriente Advisors's 13F filing for Q1 2020, filed 18 May 2020.